SECTION 1: THE PROBLEM WE SOLVE

Most seed-to-Series A biotechs face the same paradox:

You have a compelling asset. You need partners, funders, and co-development conversations. But a full-time BD hire costs $200K+ per year — before benefits, equity, and the 6–12 months it takes to onboard and produce results.

OniX Hub was built for exactly this gap.

 

We deliver fractional BD intelligence — meaning you get senior-level research, outreach, and warm introductions on a scoped monthly engagement, starting when you need it and scaling as your pipeline grows.

​

SECTION 2: THE REAL DIFFERENTIATOR — ACCESS

It's Not Just Intelligence. It's Access.

Any firm can pull a researcher list. What OniX delivers is something most BD consultants simply cannot replicate: direct, trusted access built over 25+ years on every side of the funding and partnership equation.

Three layers of access that come with every OniX engagement:

🔬 Academic & Innovation Access 1,000+ direct relationships across universities, biotech parks, and research institutions in 20+ countries — built through tenures at JDRF (managing a $650M global research portfolio) and PCORI (founding team member of a $4B congressionally mandated research institution).

💰 Funding Organization Access A verified network of 500+ funding organizations spanning:

• Federal agencies: NIH, NSF, ARPA-H, DoD, BARDA, CIHR, UKRI, FNRA, NHMRC, JSPS

• Private foundations and disease-specific nonprofits

• Venture capital and pharma-dedicated VC funds

• A growing family office network with active life sciences mandates

🤝 The Last Mile OniX doesn't just deliver names. We make direct, trusted outreach on your behalf — pre-qualifying interest, gauging IP availability, and handing you warm introductions to researchers and partners who are already engaged and expecting to hear from you.

That's the difference between a spreadsheet and a conversation that leads somewhere.

​

SECTION 3: THE ONIX AI DISCOVERY ENGINE

 

One Platform. Built Specifically for Life Sciences - Local & Private. (more details coming soon)

OniX's intelligence is powered by a proprietary agent AI platform that monitors the global research and funding landscape continuously, patents, regulatory intelligence and more.

 - see some early case studies here

1. 1 OniX Competitive Analysis Agent

Global grants, publications, clinical trials, and news — one search, several reports. Stay current in your field without anybody else knowing you're looking.​​

 

1. 2. OniX Patent Agent

Worldwide patent search across 100+ patent offices, plus a dedicated US-only mode — see where an asset sits in the patent landscape before you invest further. Requires your own free API key(s); see Setup & Instructions.

​

1. 3 OniX Regulatory Agent

Regulatory feedback and pathway analysis for a specific asset — what typically applies at a given development stage, including animal- health/veterinary questions, not just human drugs.​

​

1. 4 OniX Asset Intelligence Agent

A private due-diligence report on a specific asset — target expression, safety/toxicity, structural analog comparison, competitive landscape, regulatory hurdles, and patent landscape, all in one document. Includes a downloadable draft investor pitch-deck built from the same data.

​

1. 5 OniX Funding Agent

Federal grant programs and private foundation funding opportunities, matched to your specific research area.

​

1. 6 OniX VC & Industry Agent

Investor and industry-landscape research — funding trends, comparable deals, and market positioning.

​

SECTION 4: WHAT ONIX DOES FOR YOUR COMPANY

What a Fractional BD Engagement Actually Delivers

Depending on your pipeline and stage, an OniX engagement can include any combination of:

✓ Precision scouting of academic and industry partners aligned to your asset(s) ✓ Warm introductions to researchers and potential co-development partners — not cold emails ✓ Non-dilutive funding identification (NIH, NSF, ARPA-H, SBIR/STTR, foundations) to extend runway and de-risk assets ✓ Connection to VC, pharma VC, and family office capital networks actively deploying in your therapeutic area ✓ Competitive landscape mapping for your lead indication(s) ✓ Regulatory and reimbursement pathway assessment ✓ Monitoring of emerging global assets that could complement, compete with, or be in-licensed into your portfolio ✓ Federal co-funding partnership structuring — where OniX helps leverage your seed investment into NIH/NSF/ARPA-H matching dollars

​

All delivered on a scoped, monthly retainer — no long-term contracts, no full-time overhead.

​

SECTION 5: WHO THIS IS FOR

Is OniX Right for You?

Fractional BD engagements are designed for:

• Seed to Series A biotechs with 1–3 assets and an active pipeline

• Academic spinouts preparing for their first industry partnership or licensing conversation

• Rare disease companies needing global scouting across low-prevalence indications

• Platform technology companies seeking to identify the right disease indication and development partner simultaneously

• International biotechs entering the US market and needing NIH/federal funding navigation alongside BD support

 

If you have a compelling asset but not yet the BD infrastructure to surface the right partners and funders — OniX was built for you.

​

SECTION 6: PROOF OF CONCEPT

See What OniX Produces

OniX has completed precision scouting engagements across multiple therapeutic areas:

• Rare Bone Disease — 44 emerging researchers mapped across 15 countries, 8+ therapeutic modalities classified, 9+ funding bodies tracked simultaneously

• Hidradenitis Suppurativa — 20 researchers across 9 countries, competitive landscape and BD-ready profiles delivered

• FOP (Fibrodysplasia Ossificans Progressiva) — Active ACVR1 researcher landscape including confirmed NIH grant numbers, ClinicalTrials.gov-verified active trial PIs, and gene therapy partnership candidates

 

[See Full Case Studies →] → /case-studies

 

We are happy to run a brief scouting snapshot for one of your own indications — no commitment required. [Request a Sample →]

​

SECTION 7: HOW TO GET STARTED

Three Simple Steps

1. Book a 20-Minute Strategy Call Tell us about your pipeline, your stage, and your most pressing BD or funding need. No pitch deck required.

2. We Scope a Pilot Engagement Based on your priorities, we define the indication(s), geographies, and output format — and get started within 1–2 weeks.

3. You Receive Intelligence + Introductions Monthly deliverables, weekly status updates, and direct access to Martin throughout the engagement.

​​

[Read OniX OnPoint on Substack →] → https://onixonpoint.substack.com/